Abbott Laboratories
ABT | NYSE
$110.10
+$3.90 (+3.67%)
Nov 2, 2026, 1:43 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 928M | 1.08B | 1.78B | 1.64B | 1.78B | 1.33B | 9.23B | 1.65B | 1.3B | 1.23B | 1.59B | 1.44B | 1.38B | 1.32B | 1.03B | 1.44B | 2.02B | 2.45B | 1.99B | 2.1B | 1.19B | 1.79B |
Depreciation & Amortization | 1.01B | 730M | 792M | 791M | 777M | 756M | 807M | 801M | 805M | 805M | 813M | 824M | 800M | 806M | 807M | 815M | 822M | 823M | 883M | 847M | 874M | 934M |
Stock-Based Compensation | 168M | 317M | 113M | 120M | 142M | 289M | 111M | 117M | 141M | 304M | 114M | 117M | 132M | 281M | 115M | 123M | 142M | 305M | 106M | 114M | 132M | 288M |
Other Working Capital | 1.42B | -420M | 113M | 221M | -244M | -436M | -8.47B | n/a | n/a | n/a | -1.89B | -179M | -660M | -1.08B | -38M | 71M | 92M | -205M | -1.22B | -37M | -97M | 9.36B |
Other Non-Cash Items | -355M | 73M | 65M | n/a | n/a | n/a | 1.11B | -22M | 140M | -748M | 2.04B | -179M | -660M | n/a | 257M | 71M | n/a | n/a | 195M | n/a | n/a | -6M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 734M | -882M | 569M | 232M | -651M | -953M | -8.39B | 163M | -428M | -561M | -1.52B | -321M | -444M | -1.26B | 114M | 336M | -572M | -1.51B | -106M | -360M | -67M | -372M |
Operating Cash Flow | 2.49B | 1.32B | 3.32B | 2.79B | 2.05B | 1.42B | 2.87B | 2.71B | 1.96B | 1.03B | 3.04B | 1.88B | 1.2B | 1.14B | 2.33B | 2.78B | 2.41B | 2.07B | 3.07B | 2.7B | 2.13B | 2.64B |
Capital Expenditures | 399M | -399M | -689M | -496M | -502M | -484M | -720M | -556M | -533M | -398M | -755M | -560M | -507M | -380M | -610M | -467M | -379M | -321M | -614M | -461M | -413M | -397M |
Cash Acquisitions | -164M | -19.8B | -50M | -55M | n/a | n/a | n/a | n/a | 1M | n/a | n/a | -51M | -786M | n/a | n/a | n/a | 48M | n/a | -134M | -86M | 48M | -15M |
Purchase of Investments | n/a | -161M | -167M | 44M | -44M | n/a | -169M | n/a | 28M | -28M | -114M | -38M | 79M | -86M | -182M | -3M | 41M | -41M | -173M | -27M | 14M | -14M |
Sales Maturities Of Investments | n/a | n/a | -43M | 46M | -8M | 8M | 19M | -40M | 49M | n/a | 43M | 38M | 707M | n/a | n/a | n/a | n/a | n/a | 77M | -81M | 81M | n/a |
Other Investing Acitivies | -12M | 34M | 36M | 4M | -28M | 6M | 4M | 2M | 2M | 1M | 2M | -23M | -706M | 4M | 160M | -14M | 26M | 2M | 173M | 4M | 6M | 4M |
Investing Cash Flow | -673M | -20.32B | -913M | -457M | -582M | -470M | -866M | -594M | -453M | -425M | -824M | -634M | -1.21B | -462M | -632M | -484M | -264M | -360M | -671M | -651M | -264M | -422M |
Debt Repayment | -1.47B | 18.48B | -70M | -493M | -15M | -1.04B | -613M | 43M | 160M | -127M | -939M | -1.51B | 12M | -42M | 10M | 24M | 10M | -743M | -196M | -67M | -7M | 22M |
Common Stock Repurchased | -1.05B | -180M | -302M | -305M | -6M | -280M | -315M | -751M | -3M | -226M | -259M | -2M | -426M | -540M | -685M | -798M | -5M | -2.31B | -974M | -579M | -471M | -275M |
Dividend Paid | -1.1B | -1.1B | -1.03B | -1.03B | -1.03B | -1.03B | -958M | -960M | -961M | -957M | -888M | -888M | -890M | -890M | -823M | -826M | -828M | -832M | -798M | -801M | -803M | -800M |
Other Financial Acitivies | 100M | n/a | n/a | n/a | -82M | n/a | 25M | 92M | 13M | 134M | 34M | 56M | 15M | 62M | 41M | 57M | 10M | 59M | 82M | 70M | 17M | 86M |
Financial Cash Flow | -3.52B | 17.31B | -1.4B | -1.76B | -1.1B | -2.06B | -1.86B | -1.58B | -791M | -1.18B | -2.05B | -2.34B | -1.29B | -1.41B | -1.46B | -1.54B | -813M | -3.82B | -1.89B | -1.38B | -1.26B | -967M |
Net Cash Flow | -1.7B | -1.72B | 1.01B | 560M | 419M | -1.08B | 58M | 571M | 703M | -612M | 187M | -1.13B | -1.33B | -721M | 288M | 657M | 1.26B | -2.12B | 497M | 644M | 604M | 1.22B |
Free Cash Flow | 2.89B | 916M | 2.63B | 2.29B | 1.55B | 933M | 2.15B | 2.15B | 1.43B | 627M | 2.28B | 1.32B | 696M | 763M | 1.72B | 2.31B | 2.03B | 1.74B | 2.45B | 2.24B | 1.72B | 2.24B |
Adj. Free Cash Flow | 2.72B | 599M | 2.51B | 2.17B | 1.4B | 644M | 2.04B | 2.03B | 1.29B | 323M | 2.17B | 1.2B | 564M | 482M | 1.6B | 2.19B | 1.89B | 1.44B | 2.35B | 2.13B | 1.58B | 1.95B |
Maintenance CapEx | -399M | -399M | -558.15M | -297.97M | -295.6M | -377.7M | -526.84M | -426.35M | -427.86M | -340.82M | -715.64M | -560M | -507M | -380M | -610M | -467M | -110.03M | n/a | -408.97M | n/a | n/a | n/a |
Growth CapEx | 798M | n/a | -130.85M | -198.03M | -206.4M | -106.3M | -193.16M | -129.65M | -105.14M | -57.18M | -39.36M | n/a | n/a | n/a | n/a | n/a | -268.97M | -321M | -205.03M | -461M | -413M | -397M |
Owner Earnings | 2.09B | 916M | 2.76B | 2.49B | 1.75B | 1.04B | 2.34B | 2.28B | 1.53B | 684.18M | 2.32B | 1.32B | 696M | 763M | 1.72B | 2.31B | 2.3B | 2.07B | 2.66B | 2.7B | 2.13B | 2.64B |
Add to Watchlist
Select watchlists to add or remove ABT